Saturday 17 October 2026
Export SION’s income statement to Excel — free account
Sionna Therapeutics, Inc.
SION Healthcare Biotechnology
In the quarter to June 2026, EPS fell 61.0% and free cash flow fell 22.4%, each against the same quarter a year earlier.
3.89
0.19
−4.66%
Follow SION
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (32.34%) | (26.74%) | (105.18%) | (68.36%) |
+7 more TTM periods Free account |
|
| (30.66%) | (25.36%) | (29.42%) | (36.13%) | ||
ROIC |
(125.00%) | (85.80%) | (78.38%) | (71.16%) | |
Return on Tangible Assets |
(46.99%) | (40.12%) | (32.45%) | (28.89%) | |
Free Cash Flow per Share |
(1.68) | (1.60) | (1.67) | (1.39) | |
Free Cash Flow |
(75.92) | (71.85) | (66.67) | (61.65) | |
Capital Expenditures |
— | — | (0.38) | (0.20) | |
| Other line items | |||||
Cash ROIC |
(15.92%) | (14.25%) | (12.29%) | (10.82%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
0.78 | 0.84 | 0.88 | 0.87 | |
Depreciation/Fixed assets |
(0.47) | (0.92) | (1.08) | (1.32) | |
Capex/Depreciation |
0.00 | 0.00 | 0.16 | 0.07 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.68) | (1.60) | (1.66) | (1.39) | |
Capex per Share |
0.00 | 0.00 | (0.01) | 0.00 | |
Capex to Sales |
— | — | 0.00 | 0.00 |
Columns are period end dates